Shakil Ian's Form 4 filing
Augmedix, Inc. (AUGX) · filed Apr 4, 2024
- Accession no.
- 0001213900-24-030585
- Filed
- Apr 4, 2024
- Trade date
- Apr 3-4, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $454.5K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Shakil IanCIK 0001826129 | Director, Officer (CHIEF STRATEGY OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 3, 2024 | Common Stock | SSaleDisposed | −45,906 | $4.11 | −$188,673.66 | 95,665 | Direct | |
| Apr 4, 2024 | Common Stock | SSaleDisposed | −64,055 | $4.15F2 | −$265,828.25 | 31,610 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades ranging from $4.0800 to $4.2700. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
Referenced by the price of 1 transaction in Table I.